🔎 Trials Near Me

Hjem › Crohns sykdom › Ohio › Cleveland

Kliniske studier for Crohns sykdom i Cleveland, OH

19 studier for Crohns sykdom søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi unna
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

RekruttererFrivillige helsepersonell ønskes velkommen
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07852273

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi unna
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328

Non-nutritive Sweeteners in Inflammatory Bowel Disease

RekruttererFrivillige helsepersonell ønskes velkommen
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07769437

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekruttererFase 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07577843

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Rekrutterer
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07680283

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • UH Cleveland Medical Center /ID# 262188, Cleveland
Alder 2 til 17 · Alle kjønn · Oppdatert 24. jun. 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekruttererFase 3
  • University Children's Clinic, Cleveland
  • Cleveland Clinic, Cleveland
Alder 2 til 17 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekruttererFase 4
  • UH/Rainbow Babies and Children's Hospital, Cleveland
Alder 6 til 17 · Alle kjønn · Oppdatert 27. mai 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekruttererFase 3
  • University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Alder 2 og eldre · Alle kjønn · Oppdatert 7. mai 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

RekruttererFase 2/3
  • Cleveland Clinic Children's Hospital, Cleveland
Alder 6 til 22 · Alle kjønn · Oppdatert 5. mai 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

RekruttererFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
Alder 2 til 17 · Alle kjønn · Oppdatert 5. mai 2026 · NCT04779320

Treatment of Moderate to Severe Refractory Crohn's Disease

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 til 65 · Alle kjønn · Oppdatert 10. des. 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

RekruttererObservasjonsstudie
  • Cleveland Clinic Foundation, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT06670638

Crohns sykdom-studier i andre byer

Andre studier i Cleveland

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.